Late last month, the White House issued a statement declaring the opioid crisis a national health emergency. Many companies in the healthcare field are aware of this issue, but only a handful of pain-treating device makers are focused on fighting the crisis. Atlanta-based Medovex is aiming to be one of the few. Medovex produces the DenerveX […]
Medovex
7 medtech stories we missed this week: Sept. 22, 2017
From the FDA’s clearance of Covalon’s film-drape to Bioventus launching its study, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Covalon’s MediClear OTC surgical film-drape Covalon announced in a Sept. 21 press release that the FDA has cleared its MediClear PreOp to market in U.S. hospitals, […]
Medovex shares rise on Australian nod for DenerveX system
Medovex shares rose slightly today after the company announced it won regulatory approval from the Australian Therapeutic Goods Administration for its DenerveX system. The DenerveX system uses a slowly rotating burr to remove targeted facet joint synovial membrane and radiofrequency ablation technology to destroy tissue and denude any residual nervous and synovial membrane on the joint, […]
Neuros Medical taps ex-Sequent CEO Wilder for corner office | Personnel Moves, August 28, 2017
Neuros Medical said it named Tom Wilder, the CEO who led Sequent Medical to a $280 million acquisition by Terumo Corp. (TYO:4543), to take the corner office. “Neuros Medical, with its patented Altius system high-frequency nerve block technology, has the opportunity to develop important therapy options for patients who experience significant pain as a result […]
7 medtech stories we missed this week: Aug. 25, 2017
From InspireMD’s Swiss distribution deal to CoreLink’s stackable guide wire launch, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD announces Swiss distribution deal InspireMD announced in an Aug. 25 press release that it has signed an agreement with 1a Medical to distribute the CGuard EPS […]
Medovex touts 1st sale, commercial use of DenerveX system
Medovex said today that it sold its 1st DenerveX system, and that the device had been used in its 1st commercial procedures since winning CE Mark approval in the European Union last month. The DenerveX system uses a slowly rotating burr to remove targeted facet joint synovial membrane and radiofrequency ablation technology to destroy tissue […]
Medovex wins CE Mark for DenerveX spinal denervation system
Medical technology portfolio company Medovex said today it won CE Mark approval in the European Union for its DenerveX spinal denervation treatment system designed to treat facet joint syndrome. The DenerveX system uses a slowly rotating burr to remove targeted facet joint synovial membrane and radiofrequency ablation technology to destroy tissue and denude any residual nervous […]
Medovex sells Streamline IV suspension system assets to Skytron
Medical technology portfolio company Medovex said today it sold its Streamline IV suspension system assets to acute care focused healthcare company Skytron for an undisclosed amount. The Atlanta-based company’s Streamline ISS system is designed to mount the ISS to any bed or stretcher in hospitals and care facilities, according to Medovex’s website. Proceeds from the […]